Quantcast Mike Terretti's Daily Pharma News
Mike Terretti's Daily Pharma News By Mike Terretti 919-781-0400x112
Mike Terretti’s focus is the Pharmaceutical and Biotechnology Industries in Executive Recruitment. THe following information drives all the growth and opportunity in our market.
Web | Images | News
News HomeUSWorldBusinessFinanceIndustryTechnologyScienceMedia & AdvertisingPolitics/LawEntertainmentInternetHealthSportsCulture
Mike Terretti's Daily Pharma News >> BIOTECH November 21, 2009 members login here
Participate
Build a News Circle
Receive News Briefings
Add this Circle to favorites
Share this News Circle
Subscribe to this News Circle
Public San Francisco -Global Clinical Research -Oncology 
My Public San Francisco area client is focused on the development and commercialization of novel therapeutics for oncology.
This position in the overall management of the clinical project team and with the development of clinical plans and implementation of clinical trials.
Executive Director, Global Clinical Research and Development-Oncology

Essential functions include, but are not limited to the following:
• Oversee... Read More    Add Comment
More
>>  BIOTECH
Corn Genome Sequencing Complete
Prairie Farmer - 3 Hours ago
Scientists will develop real world applications from knowledge. Results of the Maize Genome Sequencing Project, the first comprehensive gene map of North American Corn, will be made available to the public
Sequencing of corn genome opens door Brownfield
Corn Genome Mapping Project Completed by Iowa State University Scientists EcoWorld
all 14 news articles >>      Add Comment

The Worlds Largest Earthquake-Safe Building
Gizmodo - 2 Hours ago
The new terminal at Istanbul's Sabiha Gken Airport is the world's largest earthquake-safe building. You're looking at the over two million square feet of scaffolding that support it, all resting on top
Istanbul Opens Worldâ??s Largest Earthquake-Safe Building Wired News
World's Largest Earthquake-Safe Building Wired News
all 4 news articles >>      Add Comment

Genentech & Biogen Idec get complete response letter from US FDA for Rituxan to
PharmaBiz - 17 Hours ago
Genentech, Inc, a wholly-owned member of the Roche Group and Biogen Idec announced that the US Food and Drug Administration (FDA) issued a complete response on the companies' applications for Rituxan
     Add Comment

Biotech Import Ban Creates Feed Ingredient Shortage in Turkey
Iowa Ag Connection - 19 Hours ago
In the weeks following Turkey's announcement of additional requirements on importation of all food and feed products containing genetically enhanced components, progress to reverse or amend the stringent
     Add Comment

Identifying Threat: New biometrics markets and terror culture
Corporate Watch - 71 Minutes ago
The culture of fear and distrust that has grown up around this centuryâ??s terror culture and its associated wars has created vast new markets for anything that can be branded with the words security
     Add Comment

IBM biochip allows fast diagnosis of many diseases
Planet Analog - 115 Minutes ago
MUNICH, Germany â?? In its Zurich research laboratory, IBM has built a point-of-care diagnostic test device based on a silicon chip. One chip detects up to 16 pathogens â?? and it does so faster and requiring
     Add Comment

Kernels of truth: Researchers sequence the maize genome
Farm and Dairy - 2 Hours ago
sequence of the maize (corn) genome is in the cover story of the Nov. 20 issue of Science. This new genome sequence reports the sequence of genes in maizeand provides a detailed physical map of the maize
The genetic sequence of maize could lead to better varieties SciDev.Net
Kernels of Truth: Researchers Sequence the Corn Genome US News
all 2 news articles >>      Add Comment

Breeding and genetic change in the Holstein genome
Progressive Dairy - 3 Hours ago
The average American dairy cow produces more than 20,000 pounds of milk every year. Most of these cattle are Holsteins, a breed whose naturally high milk yield has been enhanced by decades of selective
     Add Comment

Study: Health benefit costs rise 5.5%
Biz Journals - 3 Hours ago
So far, 2009 has yielded the lowest annual increase in health benefit costs in a decade, according to a survey conducted by Mercer LLC. Nationally, the average per-employee cost rose 5.5 percent to reach
Mercer: Health benefits cost Phila.-area employers 6% more this year Biz Journals
Study backs health benefits of oil from biotech soybeans SmartBrief
all 2 news articles >>      Add Comment

American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor
Financials.com - 6 Hours ago
BLAUVELT, N.Y., Nov. 19 /PRNewswire/ -- Dr. Mate Hidvegi, inventor of Avemar fermented wheat germ extract, responds to a press release issued on November 17 by Biropharma Kft, discrediting the Hungarian
     Add Comment

Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R)
KOTA Territory News - 9 Hours ago
First in the Class of Sustained Follicle Stimulants Would Reduce the Number of Treatment Injections for Patients WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc. today announced
Merck Serono: CHMP Opinion for Erbitux in Advanced Non-Small Cell Lung Cancer PharmiWeb
Merck & Co., Inc. (MRK) (JOBS) Receives CHMP Positive Opinion for New Fertility BioSpace
all 8 news articles >>      Add Comment

MALAYSIA TAPS ICGEB TO TRAIN BIOTECH SCIENTISTS
Yahoo! Malaysia - 7 Hours ago
NEW DELHI, Nov 21 (Bernama) -- Malaysia is initiating deeper alliance with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to train more local scientists in the area of treating
     Add Comment

Champions Biotechnology Enters into Licensing Agreement with Yale University and
Pharma Live - 15 Hours ago
Champions Continues to Build its Tumorgraft(TM) Driven Oncology Pipeline BALTIMORE, Nov. 18 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC:CSBR) (BULLETIN BOARD: CSBR) , an oncology drug
EcoBlu Signs Exclusive Licensing Agreement With Hartindo Fire Pro... Zibb
Champions Biotechnology signs licensing agreement with Yale University and Southern TradingMarkets
all 12 news articles >>      Add Comment

BiomedReports: News and FDA Updates for Geron (Nasdaq:GERN), NeoStem (NYSE:NBS),
Individual.com - 16 Hours ago
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news
Updates for Geron (Nasdaq:GERN), NeoStem (NYSE:NBS), Non-Invasive Monitoring Systems Los Angeles Chronicle
all 1 news articles >>      Add Comment

YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST
Genetic Engineering News - 16 Hours ago
PRWIRE M MISSISSAUGA, ON, Nov. 18 /PRwire-FirstCall/ - YM BioSciences Inc. (NYSE TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related
YM BioSciences Reports Positive Nimotuzumab Results In Advanced Triple-negative RTTNews.com
all 1 news articles >>      Add Comment

Amgen to Apply ImmunoGen TAP Technology to Another Cancer Target
Genetic Engineering News - 17 Hours ago
Amgenlicensed the exclusive right to use ImmunoGenâ??s maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics to an undisclosed target. This is the second such license
ImmunoGen announces second license agreement with Amgen Individual.com
ImmunoGen Stock Rises On Amgen Deal Investors Business Daily
all 7 news articles >>      Add Comment

Officials Laud E-Verify Users, Boost Biometric Entry Program
HR Magazine - 18 Hours ago
The page you have requested is available only to SHRM members. Please enter your membership ID and last name below. Or Join Now to get access. Membership ID: Forgot your membership ID? We can email it
     Add Comment

Biotechnology connects farmers to industry
Individual.com - 19 Hours ago
When then-Gov. Jim Hunt created the N.C. Biotechnology Center 25 years ago, most of the efforts were focused on developing products related to pharmaceuticals. But the focus is changing to include development
     Add Comment

Fish scientist key player in genome study
Straits Times - 19 Hours ago
Six-month subscription at S$36 ($6/month) 12-month subscription at S$60 ($5/month) 24-month subscription at S$102 ($4.25/month)
     Add Comment

Research and Markets Adds Report: Food Packaging - Sweden
Individual.com - 19 Hours ago
Research and Markets has announced the addition of the "Food Packaging - Sweden" report to its offerings. In a release, Research and Markets noted that report highlights include: The Packaged Food in
Research and Markets Adds Report: Dealmaking and Industry Outlook: Autoimmune and Individual.com
Research and Markets Adds Report: Molecular Diagnostics Survey 2009 Individual.com
all 12 news articles >>      Add Comment

Arcadia Biosciences, Inc. and Vilmorin Announce Strategic Alliance to Develop and
BioSpace - 20 Hours ago
DAVIS, Calif. & PARIS--(BUSINESS WIRE)--, an agricultural technology company focused on developing technologies and products that benefit the environment and human health, and Vilmorin, the worlds fourth-largest
Arcadia Biosciences and Vilmorin Announce Strategic Alliance to Develop and Market Individual.com
Arcadia signs license agreement with Vilmorin for Nitrogen Use Efficient [NUE] technology Individual.com
all 4 news articles >>      Add Comment

XOMA (US) LLC (XOMA) Receives NASDAQ Determination Letter
BioSpace - 20 Hours ago
BERKELEY, Calif., Nov. 19, 2009 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced that it received a letter from the staff of
XOMA Receives NASDAQ Determination Letter XOMA
all 1 news articles >>      Add Comment

ImmunoGen, Inc. (IMGN) Licenses Anti-Cancer Technology to Amgen (AMGN) (JOBS); ImmunoGen
BioSpace - 20 Hours ago
Reuters -- Drugmaker ImmunoGen Inc said it licensed its technology to develop anti-cancer drugs to Amgen Inc for a $1 million upfront payment.
ImmunoGen licenses anti-cancer technology to Amgen - Zibb.com Zibb
ImmunoGen licenses anti-cancer technology to Amgen Individual.com
all 7 news articles >>      Add Comment

Medidata Files for Secondary Stock Offering
Private Equity HUB - 21 Hours ago
Medidata Solutions Inc. (Nasdaq: MDSO), a New York-based provider of electronic data capture and data management software for clinical researchers, has filed for a secondary public offering of 4.5 million
Celsius Holdings Files Registration Statement for the Sale of Common Stock; Board Individual.com
Medidata files shelf registration for offering Research & Development
all 9 news articles >>      Add Comment

Monsanto aims to stop leaks at Idaho mine dump
Centre Daily Times - 5 Hours ago
BOISE, Idaho Monsanto Co. is installing a water management system at an Idaho phosphate mine the company depends on to make its Roundup weedkiller to stop the leakage of selenium and heavy metals into
     Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?
Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.